- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 10.03. | Mineralys' stock jumps as hypertension drug posts double clinical wins | ||
| 10.03. | Agomab's ALK5 inhibitor hits target in phase 2 Crohn's disease trial | ||
| 10.03. | J&J, Protagonist's oral psoriasis prospect bests BMS' Sotyktu in pair of phase 3 trials | ||
| 10.03. | Amgen ignites Rocket program with phase 3 wins for $400M eczema prospect | ||
| 07.03. | Boston Scientific backs mitral valve developer 4C Medical in $175M round | ||
| 07.03. | Nasdaq stock market plans move to 24-hour trading in US | ||
| 07.03. | NIH unveils plan to centralize grant reviews in effort to save $65M+ annually | ||
| 07.03. | FTC sues to block Surmodics acquisition by private equity over device coating competition | ||
| 07.03. | NIH still terminating research grants, defying federal orders: Boston Globe | ||
| 07.03. | Pfizer adds J&J, BMS vet James List to its executive roster as new chief internal medicine officer | ||
| 07.03. | Arcturus confident of retaining BARDA funding for bird flu trial, despite Moderna uncertainty | ||
| 07.03. | Roche to house its CVRM research work at Harvard's new research campus | ||
| 07.03. | Atea Pharmaceuticals offloads a quarter of its workforce, gears up for phase 3 HCV trials | ||
| 07.03. | Amgen and CytomX throw off masked T-cell engager, axing asset after assessing data, priorities | ||
| 07.03. | J&J fails to ace Ventura, stopping phase 3 depression program over 'insufficient efficacy' | ||
| 07.03. | Theriva puts GvHD drug on backburner to focus on oncolytic adenovirus | ||
| 06.03. | Makary connects CGMs to MAHA movement at FDA confirmation hearing | ||
| 06.03. | Zymeworks pauses plans to launch one ADC into clinic in favor of another asset | ||
| 06.03. | Tris' next-gen pain drug completes trio of clinical wins, setting up push to FDA | ||
| 06.03. | Denali's ALS drug fails to redeem itself, missing key biomarker in trial extension | ||
| 06.03. | Merck KGaA fails midphase lupus trial, says totality of data support further development | ||
| 05.03. | US judge blocks Trump administration from cutting NIH grants amid ongoing litigation | ||
| 05.03. | Trump NIH nominee Jayanta Bhattacharya says he doesn't plan on cutting more jobs in Senate hearing | ||
| 05.03. | Amgen enters Maritime, launching 2 late-stage obesity trials for MariTide | ||
| 05.03. | Ajax, KKR launch heart failure startup with Boston Scientific tech |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
